References
- Dubois C, Adriaenssens T, Annemans L, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in severe aortic stenosis patients at low surgical mortality risk: a cost-effectiveness analysis in Belgium. Acta Cardiol. 2023; in press.
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632. doi:10.1093/eurheartj/ehab395.
- Barbato E, Noc M, Baumbach A, et al. Mapping interventional cardiology in Europe: the European Association of Percutaneous Cardiovascular Interventions (EAPCI) atlas project. Eur Heart J. 202;41(27):2579–2588. doi:10.1093/eurheartj/ehaa475.
- Mylotte D, Osnabrugge TLJ, Martucci G, et al. Adoption of transcatheter aortic valve implantation in Western Europe. Interv Cardiol. 2011;9(1):37–40. doi:10.15420/icr.2011.9.1.37.
- Auffret V, Lefevre T, Van Belle E, et al. Temporal trends in transcatheter aortic valve replacement in France: France 2 to France TAVI. J Am Coll Cardiol. 2017;70(1):42–55. doi:10.1016/j.jacc.2017.04.053.
- Mauri V, Abdel-Wahab M, Bleiziffer S, et al. Temporal trends of TAVI treatment characteristics in high volume centers in Germany 2013-2020. Clin Res Cardiol. 2022;111(8):881–888. doi:10.1007/s00392-021-01963-3.
- Implantaten en invasieve medische hulpmiddelen : Lijst van de verstrekkingen en nominatieve lijsten van de individuele hulpmiddelen. Rijksinstituut voor ziekte- en invaliditeitsverzekering. https://www.riziv.fgov.be/nl/professionals/individuelezorgverleners/verstrekkers-van-implantaten/Paginas/implantaten-lijst-verstrekkingen-nominatieve.aspx.
- Standpunt transcatheter aortaklepimplantatie (TAVI) bij patiënten met symptomatische ernstige aortaklepstenose (update). https://www.zorginstituutnederland.nl/publicaties/standpunten/2020/09/30/standpunt-tavi-bij-ernstige-aortaklepstenose.
- Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276(14):1172–1177.
- Gilard M, Eltchaninoff H, Iung B, et al. Cost effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation procedure compared with surgery in patients with severe aortic stenosis at low risk of surgical mortality in France. Value Health. 2022;25(4):605–613. doi:10.1016/j.jval.2021.10.003.
- Mennini FS, Meucci F, Pesarini G, et al. Cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in low surgical risk aortic stenosis patients. Int J Cardiol. 2022;357:26–32. doi:10.1016/j.ijcard.2022.03.034.
- Kuck KH, Leidl R, Frankenstein L, et al. Cost-effectiveness of SAPIEN 3 transcatheter aortic valve implantation versus surgical aortic valve replacement in German severe aortic stenosis patients at low surgical mortality risk. Adv Ther. 2023;40(3):1031–1046. doi:10.1007/s12325-022-02392-y.
- Tchétché D, de Gennes CD, Cormerais Q, et al. Cost-effectiveness of transcatheter aortic valve implantation in patients at low surgical risk in France: a model-based analysis of the Evolut LR trial. Eur J Health Econ. 2023. doi:10.1007/s10198-023-01590-x.
- NICE: Cost-utility analysis: Transcatheter intervention for patients who have operable aortic stenosis NICE guideline NG208. 2021. https://www.nice.org.uk/guidance/ng208/evidence/tavi-economic-analysis-pdf-10890776557.
- Health Information & Quality Authority (HIQA), Ireland. https://www.hiqa.ie/sites/default/files/2019-12/TAVI_HTA.pdf.
- NIPH: Norwegian Institute of Public Health (NIPH). https://www.fhi.no/en/publ/2021/TAVI-vs-SAVR-for-patients-with-severe-aortic-stenosis-and-low-surgical-risk-and-across-surgical-risk-groups/.
- Gupta N, Verma R, Dhiman RK, et al. Cost-Effectiveness analysis and decision modelling: a tutorial for clinicians. J Clin Exp Hepatol. 2020;10(2):177–184. doi:10.1016/j.jceh.2019.11.001.
- Leon MB, Mack MJ, Hahn RT, et al. Outcomes 2 years after transcatheter aortic valve replacement in patients at low surgical risk. J Am Coll Cardiol. 2021;77(9):1149–1161. doi:10.1016/j.jacc.2020.12.052.
- Forrest JK, Deeb GM, Yakubov SJ, et al. 4-Year outcomes of patients with aortic stenosis in the evolut low risk trial. J Am Coll Cardiol. 2023:S0735-1097(23)07628-3. doi:10.1016/j.jacc.2023.09.813.
- Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement in low-risk patients at five years. N Engl J Med. 2023. doi:10.1056/NEJMoa2307447.
- Jørgensen TH, Thyregod HGH, Ihlemann N, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021;42(30):2912–2919. doi:10.1093/eurheartj/ehab375.